<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM CONDENSED
CONSOLIDATED BALANCE SHEETS, CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
AND NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS REPORTED IN FORM 10-Q
FOR THE PERIOD ENDED OCTOBER 1, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK> 0000925054
<NAME> SPECTRIAN CORP /DE/
<MULTIPLIER> 1,000
<S> <C> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> MAR-31-2001
<PERIOD-START> APR-01-2000
<PERIOD-END> OCT-01-2000
<CASH> 16,011
<SECURITIES> 28,211 <F1>
<RECEIVABLES> 24,418
<ALLOWANCES> 420
<INVENTORY> 28,059
<CURRENT-ASSETS> 104,433
<PP&E> 69,652
<DEPRECIATION> 51,187
<TOTAL-ASSETS> 124,166
<CURRENT-LIABILITIES> 29,822
<BONDS> 573
0
0
<COMMON> 12
<OTHER-SE> 93,759
<TOTAL-LIABILITY-AND-EQUITY> 124,166
<SALES> 84,106
<TOTAL-REVENUES> 84,106
<CGS> 69,982
<TOTAL-COSTS> 69,982
<OTHER-EXPENSES> 10,942 <F2>
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 89
<INCOME-PRETAX> (7,653)
<INCOME-TAX> 12
<INCOME-CONTINUING> (7,665)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (7,665)
<EPS-BASIC> (0.70) <F3>
<EPS-DILUTED> (0.70)
<FN>
<F1> Securities, Item 5-02(2), are net of accrued interest and unrealized
gain/loss.
<F2> Item consists of research and development.
<F3> Item consists of basic earnings per share.
</FN>
</TABLE>
